Shahbazkhani B, Faezi T, Akbari M R, Mohamadnejad M, Sotoudeh M, Rajab A, Tahaghoghi S, Malekzadeh R
Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, North Kargar Avenue, Tehran 14114, Iran.
Dig Liver Dis. 2004 Mar;36(3):191-4. doi: 10.1016/j.dld.2003.10.015.
The association between coeliac disease and type I diabetes mellitus has been evaluated in some previous studies, but its prevalence in Iranian diabetic patients remains unknown.
To evaluate the prevalence of coeliac disease in patients with type I diabetes mellitus in Iran.
A total of 250 consecutive patients (102 male and 148 female) with type I diabetes mellitus.
Total serum immunoglobulin A level and immunoglobulin A endomysial antibody was measured for all patients. Endoscopy and biopsy of the duodenum were performed for immunoglobulin A endomysial antibody-positive patients and pathologic evaluation was done according to modified Marsh classification.
The mean age of the patients was 18.7 years (range: 2-55 years). Total serum immunoglobulin A was in the normal range for all patients. Immunoglobulin A endomysial antibody was positive in six (2.4%) patients (all of them were females; P = 0.04). Duodenal biopsy samples revealed grade I in two patients, grade II in three patients and grade IIIb in one patient (modified Marsh classification). Patients with coeliac disease and diabetes mellitus were older than patients with diabetes mellitus alone (mean age: 29.5 years versus 18.4 years; P < 0.001). There was a trend for longer duration of diabetes mellitus in coeliac patients than in patients without it (mean age: 17.3 years versus 12.5 years; P = 0.16).
The prevalence of coeliac disease in Iranian patients with type I diabetes mellitus is relatively high (2.4%). Since almost half of the patients with coeliac disease are asymptomatic, all patients with type I diabetes mellitus should be screened for coeliac disease regardless of the presence of symptoms, at diagnosis of diabetes mellitus and with regular intervals in the follow up.
先前已有一些研究评估了乳糜泻与I型糖尿病之间的关联,但在伊朗糖尿病患者中的患病率仍不清楚。
评估伊朗I型糖尿病患者中乳糜泻的患病率。
共纳入250例连续性I型糖尿病患者(男性102例,女性148例)。
检测所有患者的血清总免疫球蛋白A水平和免疫球蛋白A型肌内膜抗体。对免疫球蛋白A型肌内膜抗体阳性患者进行十二指肠内镜检查及活检,并根据改良的马什分类法进行病理评估。
患者的平均年龄为18.7岁(范围:2 - 55岁)。所有患者的血清总免疫球蛋白A均在正常范围内。6例(2.4%)患者免疫球蛋白A型肌内膜抗体呈阳性(均为女性;P = 0.04)。十二指肠活检样本显示,2例患者为I级,3例患者为II级,1例患者为IIIb级(改良马什分类法)。合并乳糜泻和糖尿病的患者比单纯患有糖尿病的患者年龄更大(平均年龄:29.5岁对18.4岁;P < 0.001)。乳糜泻患者的糖尿病病程有长于非乳糜泻患者的趋势(平均病程:17.3年对12.5年;P = 0.16)。
伊朗I型糖尿病患者中乳糜泻的患病率相对较高(2.4%)。由于几乎一半的乳糜泻患者无症状,所有I型糖尿病患者在糖尿病诊断时及随访期间应定期进行乳糜泻筛查,无论有无症状。